ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Educational Symposium

Real-World Management of Hyperkalemia in Cardiorenal Patients

November 02, 2023 | 12:45 PM - 01:45 PM

Location: Grand Ballroom Salon D, Level 5, Philadelphia Marriott Downtown

Session Description

Hyperkalemia is a frequent complication in patients with underlying risk factors such as CKD and diabetes mellitus and with therapy with certain medications. Disturbances in the movement of potassium into cells, as well as the renal and gastrointestinal excretion of potassium, underlie the development of hyperkalemia in these patients. Importantly, recurrent and potentially life-threatening hyperkalemia commonly develops in these patients when they suffer from heart failure and are treated with drugs that target the renin-angiotensin-aldosterone system (RAAS). These include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and mineralocorticoid receptor antagonists (MRAs). However, these medications are critically important therapies to effectively manage this group of patients with heart failure and underlying cardiorenal syndrome. As such, it is a priority to undertake steps to allow these patients to remain on RAAS inhibitors and MRAs to improve overall outcomes.

This symposium provides health care providers with an update on the management of patients with cardiorenal syndrome that develop hyperkalemia when treated with RAAS inhibitors and MRAs.

Support is provided by an educational grant from CSL Vifor.

Learning Objective(s)

  • Explain the clinical importance of maintaining potassium homeostasis
  • Describe the risks and benefits of hyperkalemia in cardiorenal patients
  • Discuss the real-world management of hyperkalemia in cardiorenal patients

Learning Pathway(s)

  • Fluid‚ Electrolyte‚ and Acid-Base Disorders
  • CKD Non-Dialysis